Home > Insider Trading > Filing (0001123292-19-000750)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1661059	Nextcure Inc.	NXTC	Pharmaceutical Preparations (2834)	475231247

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1728741	Stella Xu	C/O Nextcure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville MD 20705		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-05-13	978,570	$0.00	978,570	No	4	C	Indirect	By Quan Venture Fund II, L.P.
Common Stock	Acquisiton	2019-05-13	125,000	$15.00	1,103,570	No	4	P	Indirect	By Quan Venture Fund II, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Quan Venture Fund II, L.P.
No	4	P	Indirect	By Quan Venture Fund II, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B-2 Preferred Stock	Disposition	2019-05-13	7,861,636	$0.00	978,570	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date.
The general partner of Quan Venture Fund II, L.P. is Quan Venture Partners II, L.L.C. Stella Xu is a managing director of Quan Venture Partners II, L.L.C. and shares the ultimate power to vote or dispose of the shares held by Quan Venture Fund II, L.P. Dr. Xu disclaims beneficial ownership of the shares held by Quan Venture Fund II, L.P. except to the extent of her pecuniary interest therein.